Updates
Case Study: Onboarding New Customers to VRS with OCI-Compliant Credentials
Use Case: Streamlining Secure Onboarding and Access Control with OCI-Compliant Credentials
Movilitas.Cloud Launches Free Mobile App to Streamline DSCSA Verification for Wholesalers and Pharmacists
Simple, secure mobile solution enables fast 2D barcode scanning and instant VRS responses – powered by open digital credentials and backed by Movilitas.Cloud, LedgerDomain, and Spherity
OCI’s Open Comment at the 2025 PDG-FDA Town Hall: Wholesale Distributor Exemption
OCI’s Executive Director, Bob Celeste, presented the following open comment at the PDG-FDA town hall on June 25, 2025. Industry stakeholders came together at this joint townhall to discuss DSCSA implementation efforts in advance of the wholesale distributor exemption expiry.
International digital credential adoption
From Europe to the US, Bhutan to the UN, digital credentials are transforming security, compliance, and efficiency worldwide. Let’s take a wee tour around the globe and peek at some examples.
OCI Ecosystem Encompasses Over 10,000 Pharmacies with Growing Adoption
The Open Credentialing Initiative (OCI), the leading driver of trusted digital interactions within the U.S. pharmaceutical supply chain, marks the start of 2025 with its credential ecosystem encompassing over 10,000 pharmacy locations across the United States.
State of DSCSA: Regulatory & Industry Update out of Louisiana
Louisiana Board has prepared its engagement in the enhanced drug distribution security (EDDS) network in line with PDG’s Blueprint recommendations, including the implementation of OCI-compliant digital credentials
OCI Releases VRS Performance Test Suite to Advance DSCSA Interoperability Efforts
OCI members Spherity and LedgerDomain, together with Engineering Industries eXcellence, announced the launch of an open-source Verification Router Service (VRS) performance test suite.
OCI Celebrates Major Milestone with Independent Audit Results
Drummond Group announces LedgerDomain, Legisym, and Spherity have completed OCI Conformance Program audits
Drummond Group Announces Completion of LedgerDomain OCI Digital Wallet Compliance Criteria Audit
LedgerDomain has successfully completed OCI Digital Wallet Conformance Criteria Audit to validate Pharmaceutical Authorized Trading Partners (ATP).
Drummond Group Announces Completion of Legisym OCI Credential Issuer Conformance Criteria Audit
Legisym First to Complete Compliance Audit to OCI Credential Issuer Conformance Criteria to Validate Pharmaceutical Authorized Trading Partners (ATP)
DSCSA 2024 or 2023 Déjà Vu?
A look at the challenges that need to be addressed during the FDA Stabilization Period.
Drummond Group Announces Completion of Spherity OCI Digital Wallet Compliance Criteria Audit
Spherity First to Complete Compliance Audit To OCI Digital Wallet Conformance Criteria to Validate Pharmaceutical Authorized Trading Partners (ATP)
LedgerDomain and Spherity Surpass OCI Performance Standards in Latest API Tests
LedgerDomain and Spherity, leading providers in digital credentialing services, today announced results from their latest performance testing, exceeding the current OCI requirements for the U.S. pharmaceutical supply chain under DSCSA.
OCI's Response to the FDA’s Request for Progress Reports on the Stabilization Period
OCI is honored to respond to the FDA’s request for progress reports on the Stabilization Period as we collaborate to ensure compliance with DSCSA requirements for secure, interoperable, and electronically traceable products at the package level.
OCI’s DSCSA Interoperability Specification 3.3 Expands Support to Virtual Manufacturers
The Open Credentialing Initiative (OCI), the leading driver of trusted digital interactions within the U.S. pharmaceutical supply chain, is pleased to publish its DSCSA Interoperability Specification version 3.3. This latest update incorporates support for virtual manufacturers to obtain credentials for the purposes of verification, tracing, and other activities under the Drug Supply Chain Security Act (DSCSA).